Christian Pfrepper/ResearchGate
Oct 3, 2025, 12:40
Christian Pfrepper and Team’s Letter on Emicizumab Plasma Concentration Measurment in EDTA plasma
RPTH Journal shared on LinkedIn:
”It’s mail day here at RPTH Journal
Check out this Research Letter from Christian Pfrepper and team showing that Emicizumab plasma concentration can be measured in EDTA plasma without relevant influence of residual FVIII.”
Read the full article here.
Article: Assessment of emicizumab levels in EDTA plasma
Authors: Christian Pfrepper, Annelie Siegemund, Tristan Klöter, Hagen Bönigk, Sirak Petros, Thomas Siegemund
Stay updated on all scientific advances in the field of hemophilia with Hemostasis Today.
-
Aug 26, 2026, 22:59Debbe McCall: Should Frail Elderly Patients Stable on Warfarin Switch to DOACs?
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation